HealthExec June 5, 2024
Moon Surgical has received approval from the U.S. Food and Drug Administration (FDA) to launch its futuristic laparoscopy robot. The Maestro system aids operating room staff during soft tissue surgeries by holding instruments and cameras with two maneuverable robotic arms.
The system is the first of its kind for laparoscopic surgeries and can integrate into existing systems. Moon Surgical said it will now deploy a limited release for Maestro, with full mission rollout set to happen later this year and extend into 2025.
The robot has onboard NVIDIA AI to support surgeons with real-time data on an active procedure. It’s been successfully used to treat more than 200 patients...
Today's Sponsors
Today's Sponsor